Literature DB >> 27982570

Phase-Constrained Spectrum Deconvolution for Fourier Transform Mass Spectrometry.

Dmitry Grinfeld1, Konstantin Aizikov1, Arne Kreutzmann1, Eugen Damoc1, Alexander Makarov1.   

Abstract

This Article introduces a new computationally efficient noise-tolerant signal processing method, referred to as phased spectrum deconvolution method (ΦSDM), designed for Fourier transform mass spectrometry (FT MS). ΦSDM produces interference-free mass spectra with resolution beyond the Fourier transform (FT) uncertainty limit. With a presumption that the oscillation phases are preserved, the method deconvolves an observed FT spectrum into a distribution of harmonic components bound to a fixed frequency grid, which is several times finer than that of FT. The approach shows stability under noisy conditions, and the noise levels in the resulting spectra are lower than those of the original FT spectra. Although requiring more computational power than standard FT algorithms, ΦSDM runs in a quasilinear time. The method was tested on both synthetic and experimental data, and consistently demonstrated performance superior to the FT-based methodologies, be it across the entire mass range or on a selected mass window of interest. ΦSDM promises substantial improvements in the spectral quality and the speed of FT MS instruments. It might also be beneficial for other spectroscopy approaches which require harmonic analysis for data processing.

Year:  2016        PMID: 27982570     DOI: 10.1021/acs.analchem.6b03636

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  9 in total

1.  Benchmarking the Orbitrap Tribrid Eclipse for Next Generation Multiplexed Proteomics.

Authors:  Qing Yu; Joao A Paulo; Jose Naverrete-Perea; Graeme C McAlister; Jesse D Canterbury; Derek J Bailey; Aaron M Robitaille; Romain Huguet; Vlad Zabrouskov; Steven P Gygi; Devin K Schweppe
Journal:  Anal Chem       Date:  2020-04-15       Impact factor: 6.986

2.  Metabolite Spectral Accuracy on Orbitraps.

Authors:  Xiaoyang Su; Wenyun Lu; Joshua D Rabinowitz
Journal:  Anal Chem       Date:  2017-05-18       Impact factor: 6.986

Review 3.  High-Resolution Native Mass Spectrometry.

Authors:  Sem Tamara; Maurits A den Boer; Albert J R Heck
Journal:  Chem Rev       Date:  2021-08-20       Impact factor: 72.087

4.  Noninvasive proteomic biomarkers for alcohol-related liver disease.

Authors:  Lili Niu; Maja Thiele; Philipp E Geyer; Ditlev Nytoft Rasmussen; Henry Emanuel Webel; Alberto Santos; Rajat Gupta; Florian Meier; Maximilian Strauss; Maria Kjaergaard; Katrine Lindvig; Suganya Jacobsen; Simon Rasmussen; Torben Hansen; Aleksander Krag; Matthias Mann
Journal:  Nat Med       Date:  2022-06-02       Impact factor: 87.241

5.  Assessing interference in isobaric tag-based sample multiplexing using an 18-plex interference standard.

Authors:  Jose Navarrete-Perea; Xinyue Liu; Ramin Rad; Jeremy P Gygi; Steven P Gygi; Joao A Paulo
Journal:  Proteomics       Date:  2022-01-14       Impact factor: 5.393

6.  Dynamic human liver proteome atlas reveals functional insights into disease pathways.

Authors:  Lili Niu; Philipp E Geyer; Rajat Gupta; Alberto Santos; Florian Meier; Sophia Doll; Nicolai J Wewer Albrechtsen; Sabine Klein; Cristina Ortiz; Frank E Uschner; Robert Schierwagen; Jonel Trebicka; Matthias Mann
Journal:  Mol Syst Biol       Date:  2022-05       Impact factor: 13.068

7.  Enhancing the Throughput of FT Mass Spectrometry Imaging Using Joint Compressed Sensing and Subspace Modeling.

Authors:  Yuxuan Richard Xie; Daniel C Castro; Stanislav S Rubakhin; Jonathan V Sweedler; Fan Lam
Journal:  Anal Chem       Date:  2022-03-24       Impact factor: 8.008

8.  Urinary proteome profiling for stratifying patients with familial Parkinson's disease.

Authors:  Sebastian Virreira Winter; Ozge Karayel; Maximilian T Strauss; Shalini Padmanabhan; Matthew Surface; Kalpana Merchant; Roy N Alcalay; Matthias Mann
Journal:  EMBO Mol Med       Date:  2021-01-22       Impact factor: 12.137

9.  Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson's disease.

Authors:  Ozge Karayel; Sebastian Virreira Winter; Shalini Padmanabhan; Yuliya I Kuras; Duc Tung Vu; Idil Tuncali; Kalpana Merchant; Anne-Marie Wills; Clemens R Scherzer; Matthias Mann
Journal:  Cell Rep Med       Date:  2022-06-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.